Venus Remedies Ltd.
Snapshot View

View in App

Prices View details >>

151.15 -6.15 ▼-3.9%

03 February 2023, 04:01:00 PM
Volume: 3,135

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.venusremedies.com
Market Cap 203.18 Cr.
Enterprise Value(EV) 179.37 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 11.78 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 12.83 Trailing Twelve Months Ending 2022-12
Industry PE 32.22 Trailing Twelve Months Ending 2022-12
Book Value / Share 339.72 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.44 Calculated using Price: 151.15
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.34 Cr. 13,366,988 Shares
FaceValue 10
Company Profile
Venus Remedies incorporated in 1989, is a pharmaceutical manufacturing company. The company provides formulations in area of anti-biotics and oncological therapeutics.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.91%
1 Week
-7.72%
1 Month
-16.84%
3 Month
-26.87%
6 Month
-31.70%
1 Year
-53.48%
2 Year
-14.51%
5 Year
+78.03%
10 Year
-38.02%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.38 1.12 0.38 -4.13 -8.18 -8.23 -3.05 17.40 9.85
Return on Capital Employed (%) 14.06 5.74 5.35 2.00 1.17 -0.67 0.90 12.37 7.89
Return on Assets (%) 8.29 0.62 0.20 -2.12 -4.05 -3.85 -1.45 10.30 7.18

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 462 457 438 389 362 333 323 400 440 451
Non Curr. Liab. 162 222 212 180 158 137 96 58 46 48
Curr. Liab. 211 163 193 197 230 264 225 97 93 84
Minority Int.
Equity & Liab. 834 841 843 765 751 733 644 556 579 583
Non Curr. Assets 562 608 566 506 491 467 350 322 301 287
Curr. Assets 272 233 277 259 260 265 294 234 278 295
Misc. Exp. not W/O
Total Assets 834 841 843 765 751 733 644 556 579 583

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 542 464 418 400 372 322 339 548 599 542
Other Income 0 1 2 4 2 6 5 20 8 9
Total Income 542 465 420 404 375 328 345 568 607 551
Total Expenditure -403 -375 -337 -349 -333 -289 -299 -494 -537 -501
PBIDT 139 90 83 55 42 39 46 73 70 50
Interest -29 -41 -38 -36 -36 -25 -13 -13 0 0
Depreciation -40 -46 -42 -40 -34 -34 -32 -35 -34 -32
Taxation -5 3 -2 5 -3 1 -2 13 4 -3
Exceptional Items -9 -9 23
PAT 64 5 2 -17 -31 -29 -10 62 41 16
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 64 5 2 -17 -31 -29 -10 62 41 16
Adjusted EPS 56 5 1 -14 -25 -23 -8 50 30 12

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 52 53 68 47 59 31 45 78 132 41
Cash Fr. Inv. -104 -95 -67 3 -18 -11 -11 -5 56 -17
Cash Fr. Finan. 55 40 -1 -46 -44 -39 -35 -73 -162 -9
Net Change 3 -2 -1 3 -4 -20 -1 0 26 15
Cash & Cash Eqvt 6 4 4 7 4 -20 3 2 29 43

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 35.89 35.89 40.81 40.81 40.81 40.81 41.76 41.76 41.76
Public 64.11 64.11 59.19 59.19 59.19 59.19 58.24 58.24 58.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 95.48 18.74 15.22 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 02 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Financial Results for the period ended on 31.12.2022.
Thu, 02 Feb 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Venus Remedies bags Great Place To Work certification again
Mon, 30 Jan 2023
Submission Of Unaudited Financial Results For The Period Ended On 31St December 2022
Please find enclosed herewith Unaudited Financial Results for the period ended on 31st December 2022 along with Limited Review report which were taken on record by the Board of Directors at its meeting held on 30th January 2023.

Technical Scans View Details >>

Fri, 03 Feb 2023
Close Crossing Last Month Low Close Crossing Last Month Low
Close Crossing 52 Week Low Close Crossing 52 Week Low
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Venus Remedies Ltd.

What is Venus Remedies share price?
Can I buy Venus Remedies shares now?
What is the Market Cap of Venus Remedies?
What are the key metrics to analyse Venus Remedies?
What is the 52 Week High and Low of Venus Remedies?
What is the trend of Venus Remedies share price?